Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice
Abstract Dystroglycanopathy is characterized by reduced or lack of matriglycan, a cellular receptor for laminin as well as other extracellular matrix proteins. Recent studies have delineated the glycan chain structure of the matriglycan and the pathway with key components identified. FKRP functions...
Saved in:
Main Authors: | Marcela P. Cataldi, Qi L. Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-83661-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Convenient Synthesis of 1,4-Dideoxy-1,4-imino-D-ribitol from D-Ribose
by: Makoto Oba, et al.
Published: (2013-01-01) -
D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint
by: Cheng-E Tu, et al.
Published: (2025-01-01) -
Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis
by: Selvakumar Subbian, et al.
Published: (2015-01-01) -
The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis
by: Samuel García, et al.
Published: (2015-01-01) -
Immunological efficiency of Haemophilus influenzae type b polyribosyl ribitol phosphate combined with detoxified lipooligosaccharide in a rabbit model
by: Amin Arsang, et al.
Published: (2025-02-01)